G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA™ (Trilaciclib).

Biotechnology

G1 Therapeutics

Amanda Jacobson

Shannon Lusk

Whitney Page

John Umstead V

Jeremy Paul Ware

Raj Malik

Daniel Barnes

Darlene Burns

Daren Hill

Kyle D.

Greg Maxfield

Olu O. Oyeneye

Sandi James

Monica Thomas

Mike Townsend

Jonathan P. Lindberg

The Leadership Team at G1 Therapeutics drives the strategic vision and operational execution of the company, ensuring alignment with its mission to innovate cancer therapies. Comprising key executives including the CEO, Chief Medical Officer, and Chief Business Officer, the team oversees clinical development, business strategies, and commercial initiatives to advance the company’s portfolio and maximize the impact of COSELA™ and future products on patient care.

Leadership Team

Oncology Sales and Marketing

Marketing and Communications

Leadership Team

About

Team members

Other teams at G1 Therapeutics

Oncology Sales and Marketing

Marketing and Communications